Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions – an EAU-YAU study enhancing prostate cancer detection

Fabio Zattoni, Giacomo Novara(University of Padua), Fabrizio Moro(University of Padua), Junlong Zhuang(Nanjing Drum Tower Hospital), Alessandro Marquis(Azienda Ospedaliero Universitaria San Giovanni Battista), Francesco Barletta(Vita-Salute San Raffaele University), Giancarlo Marra(Royal Free London NHS Foundation Trust), Juan Gómez Rivas(Medico), Sebastiaan Remmers(Erasmus MC), Hongqian Guo(Nanjing Drum Tower Hospital), Alberto Martini(The University of Texas MD Anderson Cancer Center), Andrea Fuschi(Sapienza University of Rome), Alessandro Antonelli(University of Pisa), Monique J. Roobol(Erasmus MC), Sabrina De Cillis, Ignacio Puche‐Sanz(Instituto de Investigación Biosanitaria de Granada), Veeru Kasivisvanathan(University College London Hospitals NHS Foundation Trust), Daniele Amparore(Ospedale San Luigi Gonzaga), Massimo Valério(University Hospital of Geneva), Riccardo Campi(University of Florence), Rossella Nicoletti(University Medical Center Utrecht), Martina Maggi(Policlinico Umberto I), Roderick C.N. van den Bergh(Erasmus MC), Giorgio Gandaglia(European School of Oncology), Riccardo Leni(Vita-Salute San Raffaele University), Jonathan Olivier(Université de Lille), Alessandro Veccia(University of Verona), Leonor J. Paulino Pereira(St. Antonius Ziekenhuis), Francesco Ditonno(Rush University), Alberto Briganti(Vita-Salute San Raffaele University), Paweł Rajwa(University College London)
Prostate Cancer and Prostatic Diseases
November 5, 2024
Cited by 10


Related Papers